WHO Immediately Sets Covid-19 Drug Guidelines

WHO Immediately Sets Covid-19 Drug Guidelines

The World Health Organization (WHO) plans to hold a meeting in the near future to make guidelines for the use of pill-type Covid-19 drugs. According to the WHO, the emergence of such a pill offers "very attractive" prospects in terms of the clinical treatment of Covid-19.

Ummatimes - The UK is the first country to approve the use of one of the Covid-19 pills this month. Janet Diaz, WHO's lead clinical trial response, estimated the meeting around the Covid-19 drug guidelines would take three weeks.

Another senior member of the WHO, Dr Mike Ryan, said the early results of a pill-type Covid-19 drug were very promising. But he still advises caution in the process of administering such pills.

"Clearly, the presence of other approaches in treating those infected (Covid-19) is a very attractive prospect," Ryan said, quoted from CGTN, Saturday, November 13, 2021.

"The hope of saving lives through such an approach is also very exciting."

Last week, the company Pfizer said its Covid-19 drug was 89 percent effective in preventing hospitalization and death among adults with severe symptoms.

At the same time, WHO legal officer Steven Solomon said that international treaty dialogue to promote preparation for a pandemic had made significant progress, even before the WHO meeting this month.

"There is good reason to believe that they (WHO members) can reach a successful conclusion," Solomon said.

Discussions at the international level have also made significant progress regarding the emergency use of the Russian-made Sputnik V vaccine, WHO official Mariangela Simao said. He said further investigations were still needed regarding Sputnik V.

"The process continues to move forward, which is certainly good news," said Simao.